As therapies and antibiotics develop and improve, pathogens adapt to overcome current medications. Bacteria are a specific organism that can adapt quickly | Immunology ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is both microscopic in size and global in consequence. The subject of Aldridge’s ...

In a classic example of scientific problem solving, scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and colleagues have published a paper introducing a promising new ...

The U.S. House on Monday unanimously adopted legislation prompted by the death last year of a 57-year-old northern Michigan woman who died from tuberculosis linked to contaminated bone graft material ...

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with 'kill switches' that can be triggered to stop the bacteria after they activate an ...

Tuberculosis bacteria survive by hiding in our immune cells. In her PhD research, biologist Salomé Muñoz Sánchez explores how ...

Here’s what you’ll learn when you read this story: Mycobacterium tuberculosis, which causes the potentially fatal respiratory infection of the same name, was found to use a system known as PrrAB to ...

Discover the transformative journey of dapsone, from textile dye to essential drug, and its impact on Hansen’s Disease treatment.